Status:

UNKNOWN

Motor Recovery Training for Hand and Digits in Stroke and SCI

Lead Sponsor:

Shirley Ryan AbilityLab

Collaborating Sponsors:

Johns Hopkins University

Conditions:

Acute Stroke

Cervical Spinal Cord Injury

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

This study will use evaluate a hand therapy device training isolated finger control with engaging video gaming technology to facilitate hand and digit recovery in patients with acute stroke and cervic...

Detailed Description

The purpose of this project is to develop a usable bedside hand therapy device that that takes advantage of early neuroplasticity following stroke and cervical spinal cord injury (SCI), to retrain fun...

Eligibility Criteria

Inclusion

  • SCI patients
  • Male and females between ages 18-75 years
  • Within 1-2 months after traumatic SCI
  • Cervical injury at C8 or above (tetraplegia)
  • Categorized by the American Spinal Cord Injury Impairment Scale (AIS) as AIS A, B, C and D. Individuals with AIS A and B will be included if they score a minimum of 1 on the "Prehension Ability" GRASSP and are able to generate 0.01N with at least one finger in dominant or non-dominant hand using the Hummingbird device.
  • Intact (level 2), impaired (level 1) or absent (level 0) lower motor neuron innervations in dermatomes C6, C7 and C8 during light touch and pin prick stimulus using the ISNCSCI sensory scores, and
  • Stroke patients
  • Males and females between ages 18-90 years
  • Within 1 month after anterior circulation ischemic stroke
  • Ability to score a minimum of 1 on the "Prehension Ability" GRASSP and are able to generate 0.01N with at least one finger in hemiparetic hand using the Hummingbird device.
  • Ability to initiate elbow flexion and extension in hemiparetic arm with gravity removed.
  • 6\. Ability to perform reaching movements towards an object at a 8 cm distance in front and above.

Exclusion

  • SCI patients
  • Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic disease
  • Any debilitating disease prior to the SCI that caused exercise intolerance
  • Other neurological injury affecting target arm and hand
  • Fracture or soft tissue injury to target arm and hand
  • A pain scored greater than 3 on a 10 point scale at rest in target arm and hand
  • Premorbid, ongoing major depression or psychosis, altered cognitive status
  • History of head injury or stroke
  • Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal cord disease such as spinal stenosis, spina bifida or herniated cervical disk.
  • Stroke patients
  • Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic disease
  • Any debilitating disease prior to the stroke that caused exercise intolerance
  • Other neurological injury affecting target arm and hand
  • Fracture or soft tissue injury to target arm and hand
  • Pain scored greater than 3 on a 10 point scale at rest in target arm and hand
  • Premorbid, ongoing major depression or psychosis, altered cognitive status
  • Inability to follow a three-step command.

Key Trial Info

Start Date :

October 20 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 27 2022

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT04688229

Start Date

October 20 2021

End Date

May 27 2022

Last Update

September 21 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.